Deepak Amarapurkar
Overview
Explore the profile of Deepak Amarapurkar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
1789
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thanapirom K, Teerasarntipan T, Treeprasertsuk S, Choudhury A, Sahu M, Maiwall R, et al.
Hepatol Int
. 2021 Nov;
16(1):171-182.
PMID: 34822057
Background And Aims: Acute-on-chronic liver failure (ACLF) is considered a main prognostic event in patients with chronic liver disease (CLD). We analyzed the 28-day and 90-day mortality in ACLF patients...
2.
Shah D, Mandot A, Cerejo C, Amarapurkar D, Pal A
J Clin Exp Hepatol
. 2020 Jan;
9(6):710-715.
PMID: 31889752
Background: Primary hepatic neuroendocrine tumor is an extremely rare entity. Only case reports are available in the literature. The aim of the study was to analyze the symptoms, diagnosis, management,...
3.
Upadhyay R, Nadka M, Muruganathan A, Tiwaskar M, Amarapurkar D, Banka N, et al.
J Assoc Physicians India
. 2018 Jun;
63(11):77-96.
PMID: 29900721
No abstract available.
4.
Vernekar M, Singhal R, Joshi K, Amarapurkar D
Metab Syndr Relat Disord
. 2018 Jun;
16(7):329-335.
PMID: 29873593
Background: Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are becoming a major cause of chronic liver diseases globally. Polyunsaturated fatty acids (PUFA) have been postulated as a potential...
5.
Somani V, Amarapurkar D, Shah A
J Clin Exp Hepatol
. 2017 Dec;
7(4):284-289.
PMID: 29234191
Background And Aims: Conventional coagulation tests (CCTs) in patients with cirrhosis only assess procoagulant factors and are poor predictors of bleeding risk. In spite of this knowledge, they are routinely...
6.
Maiwall R, Sarin S, Kumar S, Jain P, Kumar G, Bhadoria A, et al.
Liver Int
. 2017 Apr;
37(10):1497-1507.
PMID: 28393476
Background And Aim: There is limited data on predictors of acute kidney injury in acute on chronic liver failure. We developed a PIRO model (Predisposition, Injury, Response, Organ failure) for...
7.
Choudhury A, Kumar M, Sharma B, Maiwall R, Pamecha V, Moreau R, et al.
J Gastroenterol Hepatol
. 2017 Apr;
32(12):1989-1997.
PMID: 28374414
Background And Aim: Systemic inflammatory response syndrome (SIRS) is an early marker of sepsis and ongoing inflammation and has been reported in large proportion of acute-on-chronic liver failure (ACLF) patients....
8.
Amarapurkar D, Somani V, Shah A
Hepatology
. 2016 Sep;
65(2):751-752.
PMID: 27639261
No abstract available.
9.
Amarapurkar A, Nichat P, Narawane N, Amarapurkar D
Indian J Gastroenterol
. 2016 Aug;
35(4):299-304.
PMID: 27510706
Introduction: Incidence of colorectal carcinoma is increasing all over world. There is limited data on colorectal polyps from India. We evaluated the histomorphological features of colorectal polyps and determined risk...
10.
Amarapurkar D, Amarapurkar A
J Clin Exp Hepatol
. 2016 Feb;
5(4):314-9.
PMID: 26900273
Background: Liver biopsy (LB) has been used as diagnostic modality in liver diseases (LD). Over last two decades, there has been remarkable improvement in understanding of natural history, molecular diagnostics...